Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CTSO > SEC Filings for CTSO > Form 8-K on 11-Feb-2013All Recent SEC Filings

Show all filings for CYTOSORBENTS CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CYTOSORBENTS CORP


11-Feb-2013

Change in Directors or Principal Officers, Other Events, Financial Statements a


Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Effective February 8, 2013, Thomas Bocchino, Chief Financial Officer of Cytosorbents Corporation (the "Company"), resigned from his position with the Company. The resignation of Mr. Bocchino was not a result of any disagreements relating to the Company's operations, policies or practices. Mr. Bocchino has agreed to stay on part-time with the Company. Furthermore, the terms and obligations of Mr. Bocchino's employment agreement shall remain in effect for a period of thirty (30) days from Mr. Bocchino's resignation.

On the same day, the Board of Directors of the Company appointed Ronald Berger as the interim Chief Financial Officer until a new Chief Financial Officer is appointed.

Mr. Berger, 69, has performed many roles in accounting and finance, including serving as Vice President of Finance and Administration of Quick Chek Corporation and Controller of Singer Supermarkets, a member of ShopRite Supermarkets. He is a certified public accountant experienced in treasury, finance and taxes. Mr. Berger has been the Controller for the Company over the past nine years and has extensive experience in the public administration of the Company.

Family Relationships

There are no family relationships between Mr. Berger and any previous officers or directors of the Company.

Related Party Transactions

There are no related party transactions reportable under Item 5.02 of Form 8-K or Item 404(a) of Regulation S-K.

Employment Agreements

The Company does not have any employment agreement with Mr. Berger.



Item 8.01 Other Events.

Change in Chief Financial Officer

On February 8, 2013, the Company issued a press release announcing Mr. Bocchino's resignation and the appointment of Mr. Berger as the interim Chief Financial Officer, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number                         Description of Exhibit
     99.1          Press Release Dated February 8, 2013 , "CytoSorbents Appoints
                   Ronald Berger as Interim Chief Financial Officer"

  Add CTSO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CTSO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.